123. 124, 125. 126. 127. 128. 129. 130. 131. 132. 133. 134. Crile, G. Jr. Changing end results in patients with papillary carci- noma of the thyroid. Surg. Gynecol. Obstet. 132: 460-8 (1971). Hazard, J.B., Crile, G. Jr., and Dempsey, W.S. osing tumors of the thyroid. Franssila, K.O. (1975). Hazard, J.B. Nonencapsulated scler- J. Clin. Endocrinol. 9: 1215 (1949). Prognosis in thyroid carcinoma. Cancer 36: 1138-46 Small papillary carcinoma of the thyroid: A study with special reference to so-called nonencapsulated sclerosing tumor. Lab. Invest. 9: 86-97 (1960). Klinck, G.H. and Winship, T. Occult sclerosing carcinoma of the thy- roid. Cancer 8: 701 (1955). Williams, E.D. 757-9 (1975). The pathology of thyroid malignancy. Br. J. Surg. 62: Sampson, R.J., Oka, H., Key, C.R., Buncher, C.R., and Iijima, Sawin, C.T. and Hershman, J.M. The TSH response to thyrotropin-~ releasing hormone (TRH) in young adult men: Intra-individual variation and relation to basal serum TSH and thyroid hormones. J. Clin. Endocrinol. Metab. 46: 217 (1978). Thein-Wai, W. and Larsen, P.R. Effects of weekly thyroxine administration on serum thyroxine and 3,5,3'-triiodothyronine, thyrotropin and thyrotropin response to thyrotropin-releasing hormone. J. Clin. Endocrinol. Metab. 50: 660 (1980). Tunbridge, W.M.G., Evered, D.C., Hall, R., Appleton, D., Brewis, M., Clark, F., Grimley Evans, J., Young, E., Bird, T., and Smith, P.A. The spectrum of thyroid disease in a community: The Wickham survey. Clin. Endocrinol. 7: 481 (1977). Van Middlesworth, L. Factors influencing the thyroid uptake of iodine isotopes from nuclear fission: A review. Health Phys. 9: 1197-1211 (1963). 135. Evans, T.C., 136. Hodges, R.E., Evans, T.C., Bradbury, J.T., and Keettel, W.C. 137. 138. 139. 140. S. Metastases from occult thyroid carcinoma: An autopsy study from Hiroshima and Nagasaki, Japan. Cancer 25: 803-11 (1970). Fukunaga, F.H. and Yatani, R. Geographic pathology of occult thyroid carcinomas. Cancer 36: 1095-9 (1975). Kretzchmar, R.H., Hodges, R.E., and Song, C.W. uptake studies of the human fetal thyroid. (1967). Radioiodine J. Nucl. Med. 8: 157-60 ~ mulation of radioactive iodine by human fetal thyroids. The accu- J. Clin. Endocrinol. Metab. 15: 661-7 (1955). Mays, C.W. (University of Utah), Personal communication, 1974. Russel, K.P., Rose, H., and Starr, P. The effects of radioactive iodine in maternal and fetal thyroid function during pregnancy. Surg. Gynecol. Obstet. 104: 560-4 (1957). Fisher, W.D., Voorhess, M.L., and Gardner, L.I. Congenital hypothyroidism in infant following maternal 131 therapy, with a review of hazards of environmental radioisotope contamination. J. Pediat. 62: 132-46 (1963). Hamill, G.C., Jarman, J.A., and Wynne, M.D. Fetal effects of radio- active iodine therapy in a pregnant woman with thyroid cancer. Obstet. Gynecol. 81: 1018-23 (1961). - 96 ~ Am. J.